首页> 外文期刊>Journal of Controlled Release: Official Journal of the Controlled Release Society >Evaluation of cell penetrating peptides fused to elastin-like polypeptide for drug delivery
【24h】

Evaluation of cell penetrating peptides fused to elastin-like polypeptide for drug delivery

机译:评估与弹性蛋白样多肽融合的细胞穿透肽的药物递送

获取原文
获取原文并翻译 | 示例

摘要

Translocation through the plasma membrane is a major limiting step for the cellular delivery of macromolecules. Several cell penetrating peptides (CPP) have been demonstrated to efficiently internalize various molecular cargo to targets inside eukaryotic cells. In this study, the efficiency and mechanism of cellular uptake of the CPPs penetratin, Tat, and MTS fused to elastin-like polypeptides (CPP-ELP) were evaluated. Elastin-like polypeptides are biopolymers with features that make them useful as polymeric carriers for the delivery of therapeutics. Therefore, improving efficiency of cellular uptake by fusing ELPs to CPPs and understanding the mechanism of their cellular internalization could contribute to development of new therapeutic approaches. Flow cytometry and confocal fluorescence microscopy were used to elucidate the mechanism of CPP-ELP uptake. The internalization of all CPP-ELPs was impaired dramatically at 4 degrees C, under ATP depletion conditions, and with hyperosmolar sucrose, implicating involvement of an endocytic pathway for CPP-ELP internalization. Penetratin was identified as the most effective CPP for delivering ELP. Finally, in order to demonstrate the potential of CPP-ELP for drug delivery, a fusion polypeptide was made containing penetratin, ELP, and a peptide derived from the cyclin-dependent kinase inhibitor p21. This polypeptide was shown to inhibit proliferation of SKOV-3 and HeLa cells by slowing their growth rate. (c) 2005 Elsevier B.V. All rights reserved.
机译:通过质膜的转运是大分子细胞递送的主要限制步骤。几种细胞穿透肽(CPP)已被证明可以有效地将各种分子货物内在化至真核细胞内的靶标。在这项研究中,评估了与弹性蛋白样多肽(CPP-ELP)融合的CPP穿透蛋白,Tat和MTS的细胞吸收效率和机制。弹性蛋白样多肽是具有特征的生物聚合物,这些特征使它们可用作用于递送治疗剂的聚合物载体。因此,通过将ELP融合到CPP并了解其细胞内在化的机制来提高细胞摄取的效率可能有助于开发新的治疗方法。流式细胞仪和共聚焦荧光显微镜用于阐明CPP-ELP摄取的机制。所有CPP-ELP的内在化在4摄氏度,ATP耗尽条件下以及高渗蔗糖下均被大大削弱,这暗示了内吞途径参与了CPP-ELP内在化。 Penetratin被认为是递送ELP的最有效的CPP。最后,为了证明CPP-ELP在药物递送中的潜力,制得了一种融合多肽,其中含有渗透肽,ELP和衍生自细胞周期蛋白依赖性激酶抑制剂p21的肽。该多肽显示出通过减慢SKOV-3和HeLa细胞的生长速率来抑制它们的增殖。 (c)2005 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号